Abstract
Purpose
Lactose dry powder inhaler (DPI) carriers, constructed of smaller sub units (composite carriers), were evaluated to assess their potential for minimising drug–carrier adhesion, variability in drug–carrier forces and influence on drug aerosol performance from carrier–drug blends.
Methods
Lactose carrier particles were prepared by fusing sub units of lactose (either 2, 6 or 10 μm) in saturated lactose slurry. The resultant composite particles, as well as supplied lactose, were sieve fractioned to obtain a 63–90 μm carriers. The carriers were evaluated in terms of size (laser diffraction) morphology (electron microscopy and atomic force microscopy), crystallinity and drug adhesion (colloid probe microscopy). In addition, blends containing drug and carrier were prepared and evaluated in terms of drug aerosol performance.
Results
The surface morphology and physico-chemical properties of the composite carriers were significantly different. Depending on the initial primary lactose size, the composite particles could be prepared with different surface roughness. Variation in composite roughness could be related to the change in drug adhesion (via modification in contact geometry) and thus drug aerosol performance from drug–lactose blends.
Conclusion
Composite based carriers are a potential route to control drug–carrier adhesion forces and variability thus allowing more precise control of formulation performance.
Similar content being viewed by others
References
J. N. Pritchard. The influence of lung deposition on clinical response. J. Aerosol Med. 14:S19–S26 (2001). doi:10.1089/08942680150506303.
J. A. Hersey. Ordered mixing—new concept in powder mixing practice. Powder Technol. 11:41–44 (1975). doi:10.1016/0032-5910(75)80021-0.
D. Cline, and R. Dalby. Predicting the quality of powders for inhalation from surface energy and area. Pharm. Res. 19:1274–1277 (2002). doi:10.1023/A:1020338405947.
R. Price, P. M. Young, S. Edge, and J. N. Staniforth. The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations. Int. J. Pharm. 246:47–59 (2002). doi:10.1016/S0378-5173(02)00359-9.
P. M. Young, A. Sung, D. Traini, P. Kwok, H. Chiou, and H. K. Chan. Influence of humidity on the electrostatic charge and aerosol performance of dry powder inhaler carrier based systems. Pharm. Res. 24:963–970 (2007). doi:10.1007/s11095-006-9218-8.
V. Berard, E. Lesniewska, C. Andres, D. Pertuy, C. Laroche, and Y. Pourcelot. Dry powder inhaler: influence of humidity on topology and adhesion studied by AFM. Int. J. Pharm. 232:213–224 (2002). doi:10.1016/S0378-5173(01)00913-9.
X. M. Zeng, H. B. MacRitchie, C. Marriott, and G. P. Martin. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers. Int. J. Pharm. 333:45–55 (2007). doi:10.1016/j.ijpharm.2006.09.048.
N. Y. K. Chew, and H. K. Chan. Use of solid corrugated particles to enhance powder aerosol performance. Pharm. Res. 18:1570–1577 (2001). doi:10.1023/A:1013082531394.
N. Y. K. Chew, P. Tang, H. K. Chan, and J. A. Raper. How much particle surface corrugation is sufficient to improve aerosol performance of powders. Pharm. Res. 22:148–152 (2005). doi:10.1007/s11095-004-9020-4.
H. Adi, D. Traini, H. K. Chan, and P. M. Young. The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations. J. Pharm. Sci. 97:2780–2788 (2008). doi:10.1002/jps.21195.
M. D. Louey, and P. J. Stewart. Particle interactions involved in aerosol dispersion of ternary interactive mixtures. Pharm. Res. 19:1524–1531 (2002). doi:10.1023/A:1020464801786.
N. Islam, P. Stewart, I. Larson, and P. Hartley. Lactose surface modification by decantation: are drug-fine lactose ratios the key to better dispersion of salmeterol xinafoate from lactose-interactive mixtures. Pharm. Res. 21:492–499 (2004). doi:10.1023/B:PHAM.0000019304.91412.18.
P. M. Young, D. Traini, H. K. Chan, H. Chiou, S. Edge, and T. Tee. The influence of mechanical processing dry powder inhaler carriers on drug aerosolisation performance. J. Pharm. Sci. 6:1331–1341 (2007). doi:10.1002/jps.20933.
Y. Kawashima, T. Serigano, T. Hino, H. Yamamoto, and H. Takeuchi. Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. Int. J. Pharm. 172:179–188 (1998). doi:10.1016/S0378-5173(98)00202-6.
F. Ferrari, D. Cocconi, R. Bettini, F. Giordano, P. Sant, M. J. Tobyn, R. Price, P. M. Young, C. Caramella, and P. Colombo. The surface roughness of lactose particles can be modulated by wet-smoothing using a high-shear mixer. AAPS PharmSciTech. 5:1–6 (2004). doi:10.1208/pt050460.
D. El-Sabawi, S. Edge, R. Price, and P. Young. Continued investigation into the influence of loaded dose on the performance of dry powder inhalers: surface smoothing effects. Drug Dev. Ind. Pharm. 32:1135–1138 (2006). doi:10.1080/03639040600712920.
J. N. Staniforth. Pre-formulation aspects of dry powder aerosols. Proceedings of Respiratory Drug Delivery. 1:65–73 (1996).
P. M. Young, S. Edge, D. Traini, M. D. Jones, R. Price, D. El-Sabawi, C. Urry, and C. Smith. The influence of dose on the performance of dry powder inhalation systems. Int. J. Pharm. 296:26–33 (2005). doi:10.1016/j.ijpharm.2005.02.004.
K. Iida, Y. Hayakawa, H. Okamoto, K. Danjo, and H. Leuenberger. Preparation of dry powder inhalation by surface treatment of lactose carrier particles. Chem. Pharm. Bull. 51:1–5 (2003). doi:10.1248/cpb.51.1.
P. Begat, R. Price, H. Harris, D. A. V. Morton, and J. N. Staniforth. The influence of force control agents on the cohesive–adhesive balance in dry powder inhaler formulations. Kona. 23:109–121 (2005).
P. Lucas, K. Anderson, U. J. Potter, and J. N. Staniforth. Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm. Res. 16:1643–1647 (1999). doi:10.1023/A:1011981326827.
D. El-Sabawi, R. Price, S. Edge, and P. M. Young. Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations. Drug Dev. Ind. Pharm. 32:243–251 (2006). doi:10.1080/03639040500466395.
M. D. Louey, S. Razia, and P. J. Stewart. Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures. Int. J. Pharm. 252:87–98 (2003). doi:10.1016/S0378-5173(02)00621-X.
P. M. Young, D. Roberts, H. Chiou, W. Rae, H. K. Chan, and D. Traini. Composite carriers improve the aerosolisation efficiency of drugs for respiratory delivery. J. Aerosol Sci. 39:82–93 (2007). doi:10.1016/j.jaerosci.2007.10.003.
P. M. Young, D. Cocconi, P. Colombo, R. Bettini, R. Price, D. F. Steele, and M. J. Tobyn. Characterization of a surface modified dry powder inhalation carrier prepared by “particle smoothing”. J. Pharm. Pharmacol. 54:1339–1344 (2002). doi:10.1211/002235702760345400.
P. M. Young, R. Price, M. J. Tobyn, M. Buttrum, and F. Dey. Investigation into the effect of humidity on drug–drug interactions using the atomic force microscope. J. Pharm. Sci. 92:815–822 (2003). doi:10.1002/jps.10250.
P. M. Young, M. J. Tobyn, R. Price, M. Buttrum, and F. Dey. The use of colloid probe microscopy to predict aerosolization performance in dry powder inhalers: AFM and in vitro correlation. J. Pharm. Sci. 95:8100–1809 (2006).
J. H. Kirk, S. E. Dann, and C. G. Blatchford. Lactose: a definitive guide to polymorph determination. Int. J. Pharm. 334:103–114 (2007). doi:10.1016/j.ijpharm.2006.10.026.
J. H. Bushill, W. B. Wright, C. H. F. Fuller, and A. V. Bell. Crystallisation of lactose with particular reference to its occurrence in milk powder. J. Sci. Food Agric. 16:622–628 (1965). doi:10.1002/jsfa.2740161010.
R. Price, and P. M. Young. Visualization of the crystallization of lactose from the amorphous state. J. Pharm. Sci. 93:155–164 (2004). doi:10.1002/jps.10513.
O. C. Chidavaenzi, G. Buckton, F. Koosha, and R. Pathak. The use of thermal techniques to assess the impact of feed concentration on the amorphous content and polymorphic forms present in spray dried lactose. Int. J. Pharm. 159:67–74 (1997). doi:10.1016/S0378-5173(97)00272-X.
W.C. Hinds. Aerosol Technology. Willey, New York, 1999.
D. Traini, F. Thielmann, M. Acharya, K. Jarring, and P. M. Young. The influence of lactose pseudopolymorphism on salbutamol sulphate–lactose interactions in DPI formulations. Drug Dev. Ind. Pharm. 34:992–1001.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Young, P.M., Kwok, P., Adi, H. et al. Lactose Composite Carriers for Respiratory Delivery. Pharm Res 26, 802–810 (2009). https://doi.org/10.1007/s11095-008-9779-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9779-9